Restenosis after PCI. Part 1: Pathophysiology and risk factors

285Citations
Citations of this article
191Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Restenosis is a complex disease for which the pathophysiological mechanisms have not yet been fully elucidated, but are thought to include inflammation, proliferation, and matrix remodeling. Over the years, many predictive clinical, biological, (epi)genetic, lesion-related, and procedural risk factors for restenosis have been identified. These factors are not only useful in risk stratification of patients, they also contribute to our understanding of this condition. Furthermore, these factors provide evidence on which to base treatment tailored to the individual and aid in the development of novel therapeutic modalities. In this Review, we will evaluate the available evidence on the pathophysiological mechanisms of restenosis and provide an overview of the various risk factors, together with the possible clinical application of this knowledge. © 2011 Macmillan Publishers Limited. All rights reserved.

Cite

CITATION STYLE

APA

Jukema, J. W., Verschuren, J. J. W., Ahmed, T. A. N., & Quax, P. H. A. (2012, January). Restenosis after PCI. Part 1: Pathophysiology and risk factors. Nature Reviews Cardiology. https://doi.org/10.1038/nrcardio.2011.132

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free